Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.

Matthew F Kalady1, Mark W Onaitis, Karen M Padilla

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

The Journal of Surgical Research
|June 19, 2002
PubMed
Summary

Electroporation and dendritic cell maturation enhance mRNA transfection for melanoma immunotherapy. This improves antigen presentation and boosts antigen-specific T-cell responses, crucial for effective RNA-based vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients.

The American surgeon·2026
Same author

The Society of Thoracic Surgeons (2025) Expert Consensus Document on Interventions for Screen-Detected Lung Nodules.

The Annals of thoracic surgery·2026
Same author

Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.

Molecular cancer therapeutics·2025
Same author

Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy.

Surgical oncology clinics of North America·2025
Same author

ASO Visual Abstract: Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study.

Annals of surgical oncology·2025
Same author

Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study.

Annals of surgical oncology·2025

Area of Science:

  • Immunology
  • Cancer Research
  • Vaccine Development

Background:

  • Dendritic cells (DCs) are key antigen-presenting cells for immunotherapy.
  • Messenger RNA (mRNA) delivery to DCs offers a novel approach for cancer vaccines.
  • Optimizing mRNA transfection and DC maturation is critical for enhancing anti-tumor immunity.

Purpose of the Study:

  • To investigate the impact of different mRNA transfection methods on DC function.
  • To evaluate the effect of DC maturation on antigen presentation and T-cell stimulation.
  • To determine optimal strategies for generating robust anti-melanoma immune responses using mRNA-transfected DCs.

Main Methods:

  • Monocyte-derived DCs were transfected with mRNA using passive pulsing, lipofection, or electroporation.

Related Experiment Videos

  • DCs were either matured with poly(I:C) or left untreated.
  • Naïve T-cells were co-cultured with treated DCs.
  • Antigen presentation and effector T-cell generation were assessed via IFN-gamma Elispot assay.

    • Main Results:

    • Electroporation yielded the highest intracellular mRNA expression in DCs.
    • Electroporation of Mart-1/Melan A mRNA significantly enhanced specific antigen presentation.
    • DC maturation further improved antigen presentation irrespective of the transfection method.
    • Matured DCs electroporated with mRNA successfully induced antigen-specific effector T cells.

    Conclusions:

    • Electroporation is an efficient method for mRNA delivery to DCs.
    • DC maturation significantly enhances antigen presentation and T-cell induction.
    • Combining electroporation with DC maturation optimizes RNA-based vaccine efficacy for melanoma immunotherapy.